|
US2021052803A1
|
|
Therapeutic compositions for viral-associated disease states and methods of making and using same
|
|
WO2020242969A1
|
|
Chromatographic media and methods of making and using same
|
|
US2020179548A1
|
|
Autoclave operation to accommodate fluid sterilization cycles
|
|
WO2020081865A1
|
|
Adsorption and binding of plasma molecules and particles to carbon
|
|
AU2018388633A1
|
|
Tailored porosity materials and methods of making and using same
|
|
US2020353151A1
|
|
Extracorporeal circuit and column design therefore
|
|
EP3691993A1
|
|
Novel carbon foams and methods of making and using same
|
|
WO2018170320A1
|
|
Compositions and methods for the treatment of metabolic disorders
|
|
WO2018071805A1
|
|
Surface modified carbonized materials
|
|
WO2018009688A1
|
|
Novel carbon materials for use in gas storage
|
|
EP3423102A1
|
|
Method for extracorporeal treatment of preeclampsia and related disorders
|
|
WO2017173382A1
|
|
Selective adsorbent of disease mediators
|
|
US2018065062A1
|
|
Universal blood product and methods of preparing and using same
|
|
US2017304524A1
|
|
Therapeutic compositions for viral-associated disease states and methods of making and using same
|
|
CA2957011A1
|
|
Therapeutic detoxification compositions and methods of making and using same
|
|
US2015297821A1
|
|
Therapeutic compositions for viral-associated disease states and methods of making and using same
|
